SCHEMBL30830249

SCHEMBL30830249

CCOC(=O)c1cnc(C2CCCC2)nc1OC1CCCCC1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CSNK1D P48730 1/20 0.53
FOS P01100 1/20 0.47
JUN P05412 1/20 0.47
NFKB1 P19838 1/20 0.47
NFKB2 Q00653 1/20 0.47
RELA Q04206 1/20 0.47
MAOA P21397 1/20 0.44
MAOB P27338 1/20 0.44
LMNA P02545 2/20 0.41
NR2F2 P24468 2/20 0.41
NPSR1 Q6W5P4 2/20 0.41
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
NPC1 O15118 2/20 0.41
ALDH1A1 P00352 2/20 0.41
S1PR2 O95136 1/20 0.41
XBP1 P17861 1/20 0.41
RAB9A P51151 1/20 0.41
PPP1CA P62136 1/20 0.41
PDE4B Q07343 3/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26984563 1.00 CSNK1D (0.53) CSNK1DFOSJUNNFKB1NFKB2
SCHEMBL28059191 0.84 CSNK1D (0.58) CSNK1DFOSJUNNFKB1NFKB2
SCHEMBL22835196 0.83 HSP90AA1 (0.54) CSNK1DNFKB1NFKB2RELAMAOA
SCHEMBL29652040 0.83 HSP90AA1 (0.54) CSNK1DNFKB1NFKB2RELAMAOA
SCHEMBL26984530 0.83 CSNK1D (0.57) CSNK1DFOSJUNNFKB1NFKB2
SCHEMBL1015157 0.83 CSNK1D (0.43) CSNK1DFOSJUNNFKB1NFKB2
SCHEMBL30830217 0.83 CSNK1D (0.57) CSNK1DFOSJUNNFKB1NFKB2
SCHEMBL26984291 0.81 CSNK1D (0.58) CSNK1DFOSJUNNFKB1NFKB2
SCHEMBL31466879 0.81 CYP1A2 (0.64) CSNK1DFOSJUNNFKB1NFKB2
SCHEMBL26984728 0.81 CYP1A2 (0.64) CSNK1DFOSJUNNFKB1NFKB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4551555-A1 PHARMACEUTICAL COMPOSITIONS COMPRISING WRN HELICASE INHIBITORS Vividion Therapeutics, Inc. (US) 2025-05-14 EP disclosed
WO-2024010782-A1 PHARMACEUTICAL COMPOSITIONS COMPRISING WRN HELICASE INHIBITORS VIVIDION THERAPEUTICS, INC. (US) 2024-01-11 WO disclosed